Yuanmin Wang Selected Research

lupenone

12/2022

Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanmin Wang Research Topics

Disease

1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2022
1	Insulin Resistance 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Disease Progression 01/2017
1	Atherosclerosis 01/2017
1	Nephritis 01/2014
1	Nephrosis 04/2005
1	Inflammation (Inflammations) 04/2005
1	Sclerosis 04/2005

Drug/Important Bio-Agent (IBA)

2	AntigensIBA 01/2017 - 01/2014
1	Pharmaceutical PreparationsIBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	Streptozocin (Streptozotocin)FDA Link 12/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022
1	lupenoneIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AntibodiesIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	CytokinesIBA 01/2017
1	Interleukin-9 (Interleukin 9)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2005